Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Hormone-dependent prostate cancer

Recruiting

Registered drugNo placebo

A study to evaluate the effects of lutetium (177lu) vipivotide tetraxetan in patients with metastatic hormone sensitive prostate cancer receiving androgen deprivation therapy.

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Lutetium (177Lu) Vipivotide Tetraxetan

Contact Research Centre

Dyslipidaemia+1

Recruiting

Registered drug

Study of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Atorvastatin

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Plasma cell myeloma

Recruiting

Registered drugNo placebo

A study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Acute leukaemia

Recruiting

InvestigationalNo placebo

A study of Enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years

Contact Research Centre

Obsessive-compulsive disorder

Recruiting

Investigational

A study testing the safety and effectiveness of BP1.

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide

Contact Research Centre

Follicle centre lymphoma follicular grade I, II - III

Recruiting

Registered drugNo placebo

A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Myelofibrosis

Recruiting

InvestigationalNo placebo

A Study of Pacritinib for Reducing Bone Marrow Scarring in Patients with Myelofibrosis Who Have Low Platelet Counts

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Pacritinib

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

Registered drug

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Squamous cell carcinoma of head and neck

Recruiting

Registered drugNo placebo

Study of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Ivonescimab

Contact Research Centre

Acute myeloid leukaemia

Recruiting

InvestigationalNo placebo

A study comparing venetoclax, azacitidine, and quizartinib versus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia patients not suitable for standard chemotherapy

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Quizartinib Dihydrochloride

Contact Research Centre

B-cell type acute leukaemia

Recruiting

InvestigationalNo placebo

A Study to Test the Safety and How AZD4512 Works in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:AZD4512

Contact Research Centre

Find therapies in clinical trials near you – page 4

441 trials match your criteria

Hormone-dependent prostate cancer

A study to evaluate the effects of lutetium (177lu) vipivotide tetraxetan in patients with metastatic hormone sensitive prostate cancer receiving androgen deprivation therapy.

Dyslipidaemia+1

Study of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome

Acute myeloid leukaemia

Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Plasma cell myeloma

A study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant

Acute leukaemia

A study of Enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

Obsessive-compulsive disorder

A study testing the safety and effectiveness of BP1.

Follicle centre lymphoma follicular grade I, II - III

A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

Myelofibrosis

A Study of Pacritinib for Reducing Bone Marrow Scarring in Patients with Myelofibrosis Who Have Low Platelet Counts

Acute myeloid leukaemia

Study of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation

Squamous cell carcinoma of head and neck

Study of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer

Acute myeloid leukaemia

A study comparing venetoclax, azacitidine, and quizartinib versus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia patients not suitable for standard chemotherapy

B-cell type acute leukaemia

A Study to Test the Safety and How AZD4512 Works in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.